PEOPLE - Franklin Ophthalmic Instruments (US) has announced several management changes:
This article was originally published in Clinica
Franklin Ophthalmic Instruments (US) has announced several management changes, as part of its new corporate structure as Franklin.MOI. Robert Davis, past president and CEO, has resigned as chairman of the board and director. Michael Carroll has been appointed CEO, in addition to his earlier appointment as president. James Urban, who was earlier named senior vice-president and COO, has been elected chairman of the board. Dallas Talley has resigned from the board. Brian Carroll has been appointed CFO. He was formerly controller of Midwest Ophthalmic Instruments (MOI) and a co-founder of the ORIMS division of Midwest and Doctor's Financial Services.
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.